SGLT2 Inhibitor Use and Risk of Dementia and Parkinson Disease Among Patients With Type 2 Diabetes. Kim HK, Biessels GJ, Yu MH, Hong N, et al. Neurology 2024;103:e209805.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kim HK, Biessels GJ, Yu MH, Hong N, et al. SGLT2 Inhibitor Use and Risk of Dementia and Parkinson Disease Among Patients With Type 2 Diabetes. Neurology 2024;103:e209805.
PMID: 39292986